<DOC>
	<DOCNO>NCT01284556</DOCNO>
	<brief_summary>Primary : - evaluate efficacy phenobarbital reduce seizure frequency . Secondary : - confirm dose response relationship , - ass effect Type I seizure , - ass safety phenobarbital - assess drug tolerability .</brief_summary>
	<brief_title>Evaluation Phenobarbital Adjunctive Therapy Participants With Partial Onset Seizures</brief_title>
	<detailed_description>Primary : -to evaluate efficacy daily ( OD ) administration 60 mg 100 mg phenobarbital , reduce seizure frequency participant partial onset seizure ( Type I seizures ; complex simple motor symptom ) fully control despite treatment 1 3 concomitant anti-epileptic drug ( AEDs ) AEDs Vagus Nerve Stimulator ( VNS ) Secondary : - confirm dose response relationship 60 100 mg phenobarbital dos , - ass effect phenobarbital Type I seizures , - ass safety phenobarbital - ass tolerability phenobarbital</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Phenobarbital</mesh_term>
	<criteria>participant 17 70 year old ; history Type I partial onset seizure ( complex simple motor symptom ) ; participant must electroencephalogram ( EEG ) , magnetic resonance imaging ( MRI ) compute tomography ( CT ) result consistent diagnosis partialonset seizure ; participant least eight Type I partial onset seizures 8week baseline period ; participant uncontrolled treat 1 3 permit concomitant antiepileptic drug ( AED ) and/or Vagus Nerve Stimulation ( VNS ) ; participant stable dose current antiepileptic treatment regime currently take phenobarbital primidone ; currently take felbamate vigabatrin ; history prior allergic reaction phenobarbital ; history psychogenic seizure ; history presence status epilepticus ; history presence seizures occur cluster ; participant take drug possible Central Nervous System ( CNS ) effect except stable 1 month prior Visit 1 ; history cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) ; presence sign suggest rapidly progress brain disorder brain tumor ; presence unstable arteriovenous malformation , meningioma benign tumor ; history porphyria ; presence clinically significant finding physical exam , vital sign , electrocardiogram ( ECG ) safety lab assessment , include renal hepatic insufficiency ; history alcohol drug abuse within year prior screening ; participant know noncompliant ; participant male female refuse use acceptable form contraception ; female pregnant lactate intend become pregnant ; participant take part investigational device product within 2 month prior screen visit</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>partial onset seizure</keyword>
</DOC>